Evidence map›Paper›PMID 41441416›Full record

ArticleSports (Basel, Switzerland)2025

Gender Differences in Anti-Doping Rule Violations Based on a 19-Year Data Analysis from the Serbian Anti-Doping Agency: National Study.

Gorica Milovanovic, Jelena Rasic Ozegovic, Dejan Jovicic, Nenad Radivojevic, Nemanja Rancic, Jelena Stojicevic, Sonja Marjanović, Zoran Vesic, Milica Vukasinovic-Vesic

Abstract read
In one paragraph

Article in Sports (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gorica MilovanovicAnti-Doping Agency of Serbia, 11000 Belgrade, Serbia.
Jelena Rasic OzegovicAnti-Doping Agency of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-1921-4717
Dejan JovicicAnti-Doping Agency of Serbia, 11000 Belgrade, Serbia.
Nenad RadivojevicAnti-Doping Agency of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-6139-2325
Nemanja RancicDepartment of Pharmacological Sciences, Medical Faculty of the Military Medical Academy, University of Defense, 11000 Belgrade, Serbia.ORCID 0000-0002-5122-8094
Jelena StojicevicInstitute of Hygiene, Medical Faculty of the Military Medical Academy, University of Defense, 11000 Belgrade, Serbia.
Sonja MarjanovićInstitute of Hygiene, Medical Faculty of the Military Medical Academy, University of Defense, 11000 Belgrade, Serbia.
Zoran VesicDepartment for Social Work and Social Policy, Faculty of Political Sciences, University of Belgrade, 11000 Belgrade, Serbia.
Milica Vukasinovic-VesicAnti-Doping Agency of Serbia, 11000 Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGender differences in anti-doping rule violations (ADRVs) have been noted in international research, yet systematic analyses are rare. This study addresses that gap by providing the first comprehensive evaluation of the doping prevalence by gender in Serbia.

methodsA 19-year retrospective quantitative analysis was conducted on data collected by the Anti-Doping Agency of Serbia (ADAS) between 2006 and 2024. In total, 14,919 doping controls were performed, including 10,912 (73.11%) on male athletes and 4007 (26.89%) on female athletes.

resultsAcross this period, 146 ADRVs were identified, with a clear gender imbalance: 128 (87.32%) cases involved male athletes and 18 (12.68%) female athletes. A Chi-Square test confirmed a significant association between gender and ADRVs, χ

conclusionsThese findings reveal a pronounced gender disparity in doping behavior and substance choice, providing a foundation for further research and emphasizing the need for gender-sensitive anti-doping education and policy.

Indexed as

anti-doping rule violationsdopinggender differencessports

Identifiers

PMID41441416
PMCPMC12737250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.